# BAQSIMI
> **NDA210134** · New Drug Application · Sponsor: AMPHASTAR PHARMS INC · Approved 2019-07-24
## Drug
- **FDA Application Number:** NDA210134
- **Application type:** New Drug Application
- **Brand name:** BAQSIMI
- **Generic name:** GLUCAGON
- **Active ingredients:** GLUCAGON
- **Dosage form:** POWDER
- **Route:** NASAL
- **Marketing status:** Prescription
- **Sponsor:** AMPHASTAR PHARMS INC
- **Manufacturer:** Amphastar Pharmaceuticals, Inc.
- **First approval:** 2019-07-24
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210134)
---
*MORVS · CC0 1.0*